We are excited to announce that Implicity will be participating in the 92nd Annual Meeting of the German Society of Cardiology (DGK), held from April 8 to April 11, 2026, at the Rosengarten Congress Centre in Mannheim, Germany.

As one of the premier events in European cardiovascular medicine, the DGK Annual Meeting brings together thousands of healthcare professionals to explore the latest breakthroughs in heart health. For Implicity, it is a vital opportunity to demonstrate how AI-driven remote monitoring is transforming the standard of care for patients with Cardiac Implantable Electronic Devices (CIEDs).

Redefining the Patient Journey with AI

At Implicity, our mission is to simplify the complexity of cardiac data. In an era where clinicians are often overwhelmed by « alert fatigue, » our universal remote monitoring platform serves as a critical filter—ensuring that the most urgent patient needs rise to the top.

Why visit the Implicity booth in Mannheim?

• Universal Connectivity: Experience a single, streamlined interface that aggregates data from all major CIED manufacturers (Abbott, Biotronik, Boston Scientific, Medtronic and Microport).

• Clinically Proven Impact: We will be sharing the latest real-world evidence from our EVIDENCE-RM study¹, which demonstrated a 26% reduction in all-cause mortality for patients managed through our platform.

• AI-Powered Efficiency: Learn how our FDA-cleared and CE-marked algorithms² significantly reduce false-positive alerts, allowing your team to focus on high-risk patients.

Join the Conversation

The theme of the DGK 2026 meeting centers on precision medicine and the integration of digital health into daily practice. Implicity is proud to be at the forefront of this shift, helping German « Telemonitoring-Zentren » (TMZs) and clinics worldwide optimize their workflows and improve patient outcomes.

« The DGK conference is the heart of cardiology innovation in Germany. We look forward to meeting with our partners and showing how digital health tools can reduce physician workload while saving lives. » — Dr. Arnaud Rosier, CEO & Co-founder of Implicity.

Event Details at a Glance

• Event: 92. Jahrestagung der Deutschen Gesellschaft für Kardiologie (DGK)

• Dates: April 8 – 11, 2026

• Location: Congress Center Rosengarten, Mannheim, Germany

---

Schedule a Private Demo

Are you planning to attend DGK 2026? We would love to show you a personalized look at the Implicity platform.

Book a Meeting with Our Team in Mannheim

¹Niraj Varma, Eloi Marijon, Éric Vicaut, Serge Boveda, Alexandre Abraham, Issam Ibnouhsein, Arnaud Rosier, Pascal Defaye, Jagmeet P. Singh, Impact of a Universal Monitoring system (“Third party”) on Outcomes among ICD patients: A Nationwide Study, Heart Rhythm, 2024.

²IM007 ILR ECG Analyzer (CE-marked Class I (under MDD) medical device) and SignalHF are FDA-cleared Class II medical devices, see the instructions for use for more information.